AEON Biopharma (AEON) announced on Tuesday the pricing of its underwritten public offering to raise up to approximately $43.3M in gross proceeds based on the approximately $13.75M in expected gross ...

Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to ...

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...

Cue Biopharma (CUE) has appointed Dominic Borie as Chief Medical Officer and head of research & development. Borie brings more than two decades of experience leading research and clinical development ...

As a result of this latest exercise of warrants, iX Biopharma’s total number of issued shares has increased from ...

Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...

$13.75 million underwritten public offering with up to an additional $29.6 million in potential proceeds tied to the cash exercise in full of the milestone warrants issued in the offering ...

Xeris Biopharma (XERS) shares ended the last trading session 6.8% higher at $8.94. The jump came on an impressive volume with ...

Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that ...

View Sunshine Biopharma Incorporated SBFM stock quote prices, financial information, real-time forecasts, and company news from CNN.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.